Liver reserve cells

• US 5,559,022 A
• Filed: 01/26/1995
• Issued: 09/24/1996
• Est. Priority Date: 10/09/1992
• Status: Expired due to Term

• Current Assignee: RegeneMed, Inc.
• Original Assignee: Advanced Tissue Sciences, Inc.
• Inventors: Naughton, Brian A., Sibanda, Benson
• Primary Examiner(s): Rories, Charles
• Application Number:
  US08/378,762
• Time in Patent Office: 607 Days
• Field of Search: 424/93.21, 424/9.2, 424/93.1, 435/240.2, 435/172.3, 435/240.1, 935/70, 935/71
• US Class Current: 435/370
• CPC Class Codes: A61K 35/12 Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells vaccines or medicinal preparations containing antigens or antibodies A61K39/00
• CPC Class Codes: A61K 35/407 Liver; Hepatocytes
• CPC Class Codes: A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
• CPC Class Codes: A61P 1/16 for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• CPC Class Codes: C12N 5/0672 Stem cells; Progenitor cells; Precursor cells; Oval cells

Abstract

The present invention relates to liver reserve or progenitor cells. In particular, it relates to the isolation, characterization, culturing, and uses of liver reserve cells. Liver reserve cells isolated by density gradient centrifugation can be distinguished from other liver parenchymal cells by their morphology, staining characteristics, high proliferative activity and ability to differentiate in vitro. In long-term cultures described herein, these cells expand in numbers and differentiate into morphologically mature liver parenchymal cells, capable of mediating liver-specific functions. Therefore, isolated liver reserve cells may have a wide range of applications, including, but not limited to, their uses as vehicles of exogenous genes in gene therapy, and/or to replace and reconstitute a destroyed, infected, or genetically deficient mammalian liver by transplantation.

Claims

1. Isolated liver reserve cells which retain and are stained by Eosin Y dye when stained successively by a solution comprising Eosin Y dye, and then by a solution comprising both methylene blue and Azure A dyes.

2. The liver reserve cells of claim 1 which are adherent to plastic in monolayer culture.

3. The liver reserve cells of claim 2 which are adherent to other smaller liver parenchymal cells.

4. The liver reserve cells of claim 3 which have 1 or 2 nuclei, each of which contains 2 or 3 prominent nucleoli.

5. The liver reserve cells of claim 4 which have mitotic indices higher than those of other liver cells at the initiation of in vitro culture as determined by tritiated thymidine uptake.

6. The liver reserve cells of claim 5 which differentiate to give rise to cells that produce albumin and have cytochrome P-450 enzyme activity.

7. A cellular composition wherein about 90% of the cells are liver reserve cells which retain and are stained by Eosin Y dye when stained successively by a solution comprising Eosin Y dye, and then by a solution comprising both methylene blue and Azure A dyes.

8. The composition of claim 7 in which the liver reserve cells have mitotic indices higher than those of other liver cells.

9. The composition of claim 8 in which the liver reserve cells differentiate to give rise to cells that produce albumin and have cytochrome P-450 enzyme activity.

10. A method of isolating liver reserve cells comprising subjecting a mixed population of liver cells to 70% Percoll density gradient centrifugation to obtain thereby four zones, the lower two of which contain the liver reserve cells;

and pooling and centrifuging the cells in the two lower zones against a 25%/50% Percoll discontinuous gradient to obtain thereby an interface zone containing cells having a bouyant density of 1.0381 g/ml.

11. The method of claim 10 further comprising harvesting the cells from the upper portion of the interface zone to obtain a population of at least 80% of liver reserve cells.